nach oben

Erschienen in:

09.10.2017 | Clinical Mycology Lab Issues (S Córdoba, Section Editor)

Onychomycoses in a Military Population in Brazil

verfasst von: Larissa Lopes Milane Bentine, Lucas Xavier Bonfietti, Maria Walderez Szeszs, Marcia de Souza Carvalho Melhem

Erschienen in: Current Fungal Infection Reports | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This study aimed to isolate and characterize filamentous fungi onychomycosis agents in a military population assisted at a hospital outpatient clinic.

Recent Findings

In onychomycosis, the fungi colonize the subungual region causing thickening, discoloration, or cracking of the nail bed. Samples were collected from patients with clinical sights of onychomycosis.

Summary

Among 80 samples collected, 50 (62.5%) had positive culture. Isolated dermatophytes (86%) were Trichophyton rubrum (21; 42%), T. mentagrophytes var. interdigitale (19; 38%), and Microsporum gypseum (3; 6%) and non-dermatophyte molds were Fusarium spp. (1; 2%), Scytalidium spp. (1; 2%), and Chaetomium globosum (5; 10%). Minimal inhibitory concentrations (mg/L) of terbinafine, itraconazole, and fluconazole necessary to inhibit 50/90% of the isolates were respectively 0.015/0.06, 0.06/0.12, and 32/32. Etiological agents of onychomycosis in a military hospital are similar as reported in studies for the general population. High prevalence of non-dermatophytic agents was observed, especially for Chaetomium globosum.

Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641–8.CrossRefPubMed

Mahoney JM, Bennet J, Olsen B. The diagnosis of onychomycosis. Dermatol Clin. 2003;21:463–7.CrossRefPubMed

Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11(3):415–29.PubMedPubMedCentral

Katoh T. Guidelines for diagnosis and treatment of mucocutaneous candidiasis. Jpn J Med Mycol. 2009;50:207–12.CrossRef

Iorizzo M, Piraccini BM, Rech G, Tosti A. Treatment of onychomycosis with oral antifungal agents. Expert Opin Drug Deliv. 2005;2:435–40.CrossRefPubMed

Stüttgen G, Bauer E. Bioavailability, skin- and nailpenetration of topically applied antimycotics. Mycoses. 1982;25:74–80.CrossRef

Santos DA, Barros MES, Hamdan JS. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes. J Clin Microbiol. 2006;44:98–101.CrossRefPubMedPubMedCentral

Silva Barros ME, de Assis SD, Hamdan JS. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J Med Microbiol. 2007;56:514–8.CrossRefPubMed

Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M. British Association of Dermatologists’ guidelines for the management of onychomycosis. Br J Dermatol. 2014;171:937–58.CrossRefPubMed

10.

Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol. 1992;126:23–7.CrossRefPubMed

11.

Aly R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol. 1994;31:21–5.CrossRef

12.

Scher RK, Baran R. Onychomycosis in clinical practice: factors contributing to recurrence. Br J Dermatol. 2003;149:5–9.CrossRefPubMed

13.

Segal R, Shemer A, Hochberg M, et al. Onychomycosis in Israel: epidemiological aspects. Mycoses. 2015;58:133–9.CrossRefPubMed

14.

Drakensjö IT, Chryssanthou E. Epidemiology of dermatophyte infections in Stockholm, Sweden: a retrospective study from 2005–2009. Med Mycol. 2011;49:484–8.PubMed

15.

Saunte D, Svejgaard E, Haedersdal M, Frimodt-Møller N, Jensen AM, Arendrup CM. Laboratory-based survey of dermatophyte infections in Denmark over a 10-year period. Acta Derm Venereol. 2008;88:614–6.PubMed

16.

Tchernev G, Penev PK, Nenoff P, et al. Onychomycosis: modern diagnostic and treatment approaches. Wien Med Wochenschr. 2013;163:1–12.CrossRefPubMed

17.

Dolenc-Voljc M. Dermatophyte infections in the Ljubljana region, Slovenia, 1995–2002. Mycoses. 2005;48:181–6.CrossRefPubMed

18.

Garg A, Venkatesh V, Singh M, Pathak KP, Kaushal GP, Agrawal SK. Onychomycosis in central India: a clinicoetiologic correlation. Int J Dermatol. 2004;43:498–502.CrossRefPubMed

19.

Nzenze Afene S, Ngoungou EB, Mabika Mamfoumbi M, Bouyou Akotet MK, Avome Mba IM, Kombila M. Les onychomycoses au Gabon: aspects cliniques et mycologiques. J Mycol Med. 2011;21:248–55.CrossRef

20.

Summerbell RC, Cooper E, Bunn U, Jamieson F, Gupta AK. Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes. Med Mycol. 2005;43:39–59.CrossRefPubMed

21.

Gupta AK, Cooper EA, MacDonald P, Summerbell RC. Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi. J Clin Microbiol. 2001;39:2115–22.CrossRefPubMedPubMedCentral

22.

Kemna ASCP, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol. 1996;35:539–42.CrossRefPubMed

23.

Koussidou T, Devliotou-Panagiotidou D, Karakatsanis G, et al. Onychomycosis in Northern Greece during 1994–1998. Mycoses. 2002;45:29–37.CrossRefPubMed

24.

Gianni C, Cerri A, Crosti C. Non-dermatophytic onychomycosis. An underestimated entity? A study of 51 cases. Mycoses. 2000;43:29–33.CrossRefPubMed

25.

Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000;42:217–24.CrossRefPubMed

26.

Heikkila H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol. 1995;133:699–703.CrossRefPubMed

27.

Clayton YM. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses. Clin Exp Dermatol. 1992;17:37–40.CrossRefPubMed

28.

Maraki S, Nioti E, Mantadakis E, Tselentis Y. A 7-year survey of dermatophytoses in Crete, Greece. Mycoses. 2007;50:481–4.CrossRefPubMed

29.

El Sayed F, Ammoury A, Haybe RF, Dhaybi R. Onychomycosis in Lebanon: a mycological survey of 772 patients. Mycoses. 2006;49:216–9.CrossRefPubMed

30.

Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists’ offices in Ontario, Canada—a multicenter survey of 2001 patients. Int J Dermatol. 1997;6:783–7.CrossRef

31.

Araújo AJG, Souza MAJ, Bastos OM, Oliveira JC. Onychomycosis caused by emergent fungi: clinical analysis, diagnosis and revision. An Bras Dermatol. 2003;78:445–55.CrossRef

32.

Brilhante RSN, Paixão GC, Salvino LK, Diógenes MJN, Bandeira SP, Rocha MFG, et al. Epidemiologia e ecologia das dermatofitoses na cidade de Fortaleza: o Trichophyton tonsurans como importante patógeno emergente da Tinea capitis. Rev Soc Bras Med Trop. 2000;33:417–25.CrossRefPubMed

33.

Costa M, Passos XS, Souza LKH, Miranda ATB, Lemos JÁ, Júnior JGO, et al. Epidemiologia e etiologia das dermatofitoses em Goiânia, GO, Brasil. Rev Soc Bras Med Trop. 2002;35:19–22.CrossRefPubMed

34.

Lacaz CS, Porto E, Melo NT. Guia para identificação: fungos, actimomicetos e algas de interesse medico. 1a edição. São Paulo: Savier; 1998.

35.

Bassiri-Jahromi S, Khaksar AA. Nondermatophytic moulds as a causative agent of onychomycosis in Tehran. Indian J Dermatol. 2010;55:140–3.CrossRefPubMedPubMedCentral

36.

Hilmioğlu-Polat S, Metin DY, Inci R, Dereli T, Kilinç I, Tümbay E. Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey—a prospective study. Mycopathologia. 2005;160:125–8.CrossRefPubMed

37.

Ramani R, Srinivas CR, Ramani A, Kumari TG, Shivananda PG. Molds in onychomycosis. Int J Dermatol. 1993;32:877–8.CrossRefPubMed

38.

Stiller MJ, Rosenthal S, Summerbell RC, et al. Onychomycosis of the toenails caused by Chaetomium globosum. J Am Acad Dermatol. 1992;26:775–6.CrossRefPubMed

39.

Rippon JW. Medical mycology: the pathogenic fungi and the pathogenic actinomycetes, 3rd ed. Philadelphia: W.B. Saunders Co.; 1988.

40.

Hattori N, Adachi M, Kaneko T, Shimozuma M, Ichinohe M, Iozumi K. Case report. Onychomycosis due to Chaetomium globosum successfully treated with itraconazole. Mycoses. 2000;43:89–92.CrossRefPubMed

41.

Naidu J, Singh SM, Pouranik M. Onychomycosis caused by Chaetomium globosum Kunze. Mycopathologia. 1991;113:31–4.CrossRefPubMed

42.

Fernández-Torres B, Carrillo AJ, Martín E, Del Palacio A, Moore MK, Valverde A, et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother. 2001;45:2524–8.CrossRefPubMedPubMedCentral

43.

Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother. 2003;47:82–6.CrossRefPubMedPubMedCentral

44.

Tamura T, Asahara M, Yamamoto M, Yamaura M, Matsumura M, Goto K, et al. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evalution by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dematophytes. Microbiol Immunol. 2014;58:1–8.CrossRefPubMed

45.

Carrillo-Muñoz AJ, Guglietta A, Palacín C, Casals J, del Valle O, Guardià C, et al. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis. Chemotherapy. 2004;50:308–13.CrossRefPubMed

46.

Yamazaki H, Nakamoto M, Shimizu M, Murayama N, Niwa T. Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles. Br J Clin Pharmacol. 2010;69:593–7.CrossRefPubMedPubMedCentral

47.

Jessup CJ, Ryder NS, Ghannoum MA. An evaluation of the in vitro activity of terbinafine. Med Mycol. 2000;38:155–9.CrossRefPubMed

48.

Osborne CS, Hofbauer B, Favre B, Ryder NS. In vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafine. Antimicrob Agents Chemother. 2003;47:3634–6.CrossRefPubMedPubMedCentral

Titel: Onychomycoses in a Military Population in Brazil
verfasst von: Larissa Lopes Milane Bentine
Lucas Xavier Bonfietti
Maria Walderez Szeszs
Marcia de Souza Carvalho Melhem
Publikationsdatum: 09.10.2017
Verlag: Springer US
Erschienen in: Current Fungal Infection Reports / Ausgabe 4/2017
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-017-0291-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

16.04.2024 | Chronische Herzinsuffizienz | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Onychomycoses in a Military Population in Brazil

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Innere Medizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

What Is New? Recent Knowledge on Fungal Extracellular Vesicles

Time-Kill Curves Studies with Amphotericin B Against Cryptococcus neoformans/C. gattii Species Complex Clinical Isolates

Clinical Implications of Candida Biofilms

Contribution of the National Mycology Laboratory Network to Surveillance of Cryptococcosis in Argentina

A Comprehensive Analysis of MALDI-TOF MS and Ribosomal DNA Sequencing for Identification of Clinical Yeasts

Candida auris: Antifungal Multi-Resistant Emerging Yeast

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Innere Medizin